A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION

BACKGROUND: Therapeutic drug monitoring (TDM) of infliximab (IFX) as indicated in patients with loss of response (LOR) (known as reactive strategy) is a widely accepted strategy in the management of patients with inflammatory bowel disease (IBD). Proactive drug monitoring of IFX trough levels has be...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Can Assoc Gastroenterol
Asıl Yazarlar: Stern, N C, Fedorak, R, Wong, K, Halloran, B P, Dieleman, L A, Huang, V, Peerani, F, Kroeker, K I
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Paper Sessions
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508429/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.137
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller